摘要
糖尿病视网膜病变是最常见的糖尿病微血管病变。目前有很多致力于延缓糖尿病视网膜病变的药物研究,包括对肾素-血管紧张素系统阻滞剂、蛋白激酶C抑制剂、血管内皮生长因子抑制剂、生长抑素类似物、抗炎药物、晚期糖基化终末产物抑制剂及醛糖还原酶抑制剂等的研究。本文就近几年在这些方面的研究工作作一综述。
Diabetic retinopathy, the most common microvascular complication of diabetes, is the leading cause of blindness. Many methods or drugs have been used to prevent the development of it, including iulfibition of renin-angiotensin system, protein kinase C iuhibitors, inhibitors of vascular endothelial growth factor, analogs of somatostatin, anti-inflammatory treatment, advanced glycation end products inhibitors, aldose reductase inhibitors, etc. This review focuses on the recent investigations in medication of diabetic retinopathy.
出处
《国际内分泌代谢杂志》
2006年第B04期3-6,共4页
International Journal of Endocrinology and Metabolism
基金
上海市科委科研计划项目(034119818)
